News

Methylphenidate Tied to Greater Risk for Arrhythmia in Children, Adolescents

Author and Disclosure Information

Key clinical point: Use of methylphenidate to treat children with attention-deficit/hyperactivity disorder (ADHD) can lead to higher risk for arrhythmia, especially in the first 3 days of use.

Major finding: The risk of arrhythmia increased during periods of treatment with methylphenidate when compared with other treatment periods (incidence rate ratio, 1.61), and reached 2.01 during the first 1-3 days of methylphenidate treatment.

Data source: A retrospective case series analysis of 1,224 patients at or younger than 17 years of age, who had at least one recorded cardiovascular event and one prescription for methylphenidate.

Disclosures: Two coauthors disclosed receiving support via fellowships from Australia’s National Health and Medical Research Council.


 

FROM THE BMJ

References

Children and adolescents with attention-deficit/hyperactivity disorder who are prescribed methylphenidate to manage their conditions stand at a higher risk for arrhythmia and other, more serious, cardiac conditions.

In a study published in the BMJ, Ju-Young Shin, Ph.D., and colleagues examined records of 1,224 patients aged 17 years and younger from a nationwide South Korean health insurance database submitted between January 2007 and December 2011. All of the patients had experienced a cardiovascular event and at least one recorded prescription for methylphenidate to treat attention-deficit/hyperactivity disorder (ADHD) (BMJ 2016;353:i2550 doi:10.1136/bmj.i2550).

©mik38/thinkstockphotos.com

Of the 1,224 subjects, 864 (70.5%) had experienced arrhythmias, and the mean duration of exposure to methylphenidate was 0.5 years. During periods of methylphenidate treatment, subjects had an increased risk of arrhythmia, as Dr. Shin and coinvestigators calculated an adjusted incidence rate ratio of 1.61 (95% confidence interval, 1.48-1.74). This incidence rate ratio jumped up to 2.01 (95% CI, 1.74-2.31) during the first 3 days of methylphenidate treatment.

The risk was even higher for subjects with congenital heart disease; this subgroup had an adjusted incidence rate ratio of 3.49 (95% CI, 2.33-5.22), compared with 1.34 (95% CI, 1.23-1.46) in patients without it. Both the median age of first exposure to methylphenidate and occurrence of the first cardiac event were in patients aged 11-13 years, reported Dr. Shin of the Centre for Clinical Epidemiology at Jewish General Hospital and McGill University, both in Montreal, and colleagues in Australia and Korea.

“These results are consistent with the biological plausibility that the mechanism of action relates to the effect of methylphenidate on the heart rate,” the authors concluded. “Delayed effects would be expected with myocardial infarction, while more immediate effects would be expected with arrhythmias, as we observed.”

Dr. Shin and colleagues cited several limitations. For example, coding mistakes and incomplete records could not be ruled out in their study. In addition, they said, the “outcome measures were limited to patients with diagnoses of cardiovascular adverse events, and we could have missed outcomes not diagnosed.”

Nevertheless, they said, in light of the increased use of methylphenidate to treat ADHD across the globe, the benefits of using the drug “should be carefully weighed against potential cardiovascular risks of these drugs in children and adolescents.”

Two of the authors disclosed receiving support via fellowships from Australia’s National Health and Medical Research Council.

Recommended Reading

Acute Heart Failure Mortality Climbs With Severity of Peripheral Edema
Clinician Reviews
Exercise Linked to Fewer Cardiovascular Events in Nonmetastatic Breast Cancer Patients
Clinician Reviews
Marijuana May Lower Death Risk After Acute MI
Clinician Reviews
Stroke Risk Rises Quickly in Recent-onset Atrial Fib
Clinician Reviews
Lipoprotein(a) and Cardiovascular Disease
Clinician Reviews
“Go Low” or “Say No” to Aggressive Systolic BP Goals?
Clinician Reviews
AF and Stroke May Be Temporally Related
Clinician Reviews
Congenital Heart Disease Screening Cuts Infant Mortality
Clinician Reviews
Flu Vaccination Cut Hospitalizations in Heart Failure Patients
Clinician Reviews
Exercise Is Protective but Underutilized in Atrial Fib Patients
Clinician Reviews